PROCEPT BioRobotics (PRCT) Short-term Investments (2022 - 2023)
PROCEPT BioRobotics' (PRCT) quarterly Short-term Investments came in at $777000.0 in Q3 2023, little changed on a QoQ basis from $777000.0 in Q2 2023.
PROCEPT BioRobotics (PRCT) Short-term Investments (2022 - 2023) Analysis & Trends
PROCEPT BioRobotics (PRCT) has 2 years of Short-term Investments data on file, last reported at $777000.0 in Q3 2023.
- On a quarterly basis, Short-term Investments changed N/A year-over-year to $777000.0 in Q3 2023; TTM through Sep 2023 was $777000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $777000.0, changed N/A from the prior year.
- Short-term Investments for Q3 2023 stood at $777000.0, roughly flat from $777000.0 in the prior quarter.
- Over the last five years, Short-term Investments for PRCT reached as high as $777000.0 in Q4 2022 and fell as low as $777000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | PROCEPT BioRobotics | 1.00 Bn | 757.43 Mn | 53.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 777,000.00 |
| Jun 30, 2023 | 777,000.00 |
| Mar 31, 2023 | 777,000.00 |
| Dec 31, 2022 | 777,000.00 |